Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
Serena Fasano, Antonella Riccardi, Valentina Messiniti, Paola Caramaschi, Edoardo Rosato, Britta Maurer, Vanessa Smith, Elise Siegert, Ellen De Langhe, Valeria Riccieri, Paolo Airó, Carina Mihai, Jerome Avouac, Elisabetta Zanatta, Ulrich A Walker, Florenzo Iannone, Paloma García De la Peña Lefebvre, Jörg H W Distler, Alessandra Vacca, Oliver Distler, Otylia Kowal-Bielecka, Yannick Allanore, Gabriele Valentini
Annals of the Rheumatic Diseases Dec 2019, 78 (12) 1681-1685; DOI: 10.1136/annrheumdis-2019-215787
